592
Participants
Start Date
January 18, 2023
Primary Completion Date
October 8, 2024
Study Completion Date
January 2, 2026
Maridebart Cafraglutide
Participants will receive maridebart cafraglutide by subcutaneous (SC) injection.
Placebo
Participants will receive placebo by SC injection.
Budapesti Szent Ferenc Korhaz, Budapest
Clinexpert Kft, Budapest
Royal Prince Alfred Hospital (RPAH) Clinic, Camperdown
Baker Heart and Diabetes Institute, Melbourne
St Vincents Hospital Melbourne, Fitzroy
Austin Health, Heidelberg Repatriation Hospital, Heidelberg Heights
Monash Medical Centre, Clayton
CRU Hungary Kft, Encs
Clinical Medical and Analytical eXellence CMAX, Adelaide
Pecsi Tudomanyegyetem Klinikai Kozpont, Pécs
National Taiwan University Hospital, Taipei
Charite - Universitaetsmedizin Berlin, Campus Mitte, Berlin
Dongguk University Ilsan Hospital, Goyang-si, Gyeonggi-do
State University of New York Upstate Medical University, Syracuse
Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do
Complexo Hospitalario Universitario A Coruña, A Coruña
Gachon University Gil Medical Center, Incheon
Diabeteszentrum Hamburg West, Hamburg
Hospital Universitario Arnau de Vilanova Lleida, Lleida
Lucas Research, Morehead City
Hospital Clinico Universitario Virgen de la Victoria, Málaga
Progressive Medical Research, Port Orange
Alliance for Multispecialty Research Miami, Coral Gables
Alliance for Multispecialty Research Mobile, Mobile
Medical Care LLC, Elizabethton
Louisville Metabolic and Atherosclerosis Research Center, Louisville
China Medical University Hospital, Taichung
Hospital Vithas Sevilla, Castilleja de la Cuesta
The Christ Hospital, Cincinnati
Research Innovations LLC dba Internal Medicine Care Inc, Beavercreek
University of Chicago, Chicago
Great Lakes Clinical Trials, Chicago
StudyMetrix Research, City of Saint Peters
Alliance for Multispecialty Research Kansas City, Kansas City
Alliance for Multispecialty Research Newton, Newton
Tandem Clinical Research - Marrero, Marrero
National Cheng Kung University Hospital, Tainan City
Alliance for Multispecialty Research Norman, Norman
Clinical Trials of Texas, San Antonio
Diabetes and Glandular Disease Clinic, San Antonio
Pinnacle Clinical Research, San Antonio
Texas Diabetes Institute, San Antonio
PanAmerican Clinical Research LLC, Brownsville
Headlands Research Brownsville, Brownsville
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City
Foothills Research Center, Phoenix
HonorHealth, Scottsdale
Ark Clinical Research- Long Beach, Long Beach
Ark Clinical Research- Tustin, Tustin
Orange County Research Center, Tustin
Diablo Clinical Research, Walnut Creek
East-West Medical Research, Honolulu
University of Calgary, Calgary
Centricity Research Brampton Endocrinology, Brampton
Centricity Research Vaughan Endocrinology, Concord
Institut Universitaire de cardiologie et de pneumologie de Quebec, Québec
Clinique des Maladies Lipidiques de Quebec Incorporated, Québec
Endokrinologicky ustav, Prague
Vseobecna fakultni nemocnice v Praze, Prague
Institut klinicke a experimentalni mediciny, Prague
Universitaetsmedizin Leipzig, Leipzig
Prince of Wales Hospital, Shatin, New Territories
Mikannohana Clinic, Diabetes, Endocrinology and Metabolism, Matsuyama
Wellness Tenjin Clinic, Fukuoka
Matsunami Health Promotion Clinic, Hashima-gun
Mazda Hospital of Mazda Motor Corporation, Aki-gun
Nakakinen Clinic, Naka
Nishiyamado Keiwa Hospital, Naka
Shiraiwa Medical Clinic, Kashiwara-shi
Nihonbashi Sakura Clinic, Chuo-ku
MIH Clinic Yoyogi, Shibuya-ku
AthleticoMed, Bydgoszcz
Centrum Badan Klinicznych PI-House Spzoo, Gdansk
Centrum Terapii Wspolczesnej, Lodz
AppleTreeClinics Network Spzoo, Lodz
Clinical Best Solutions Sp zoo Spolka Komandytowa, Lublin
Migre Polskie Centrum Leczenia Migreny Anna Gryglas-Dworak, Wroclaw
Kangbuk Samsung Hospital, Seoul
Lead Sponsor
Amgen
INDUSTRY